Several central nervous system (CNS) proteins are associated with disease and are either known or potential targets for cysteine cathepsins, including amyloid beta and Tau (Alzheimer’s disease), alpha-synuclein (Parkinson’s disease), and myelin basic protein (MBP, multiple sclerosis) [11]. Here, MBP is linked to early-onset autosomal dominant Alzheimer disease.